Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 102

Published Date: 23 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Inactivated Polio Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. The oral polio vaccine has the risk of transmission through human waste, causing the regulatory bodies to shift their demand towards IPV. Inactivated polio vaccines (IPV) have now been introduced into all countries’ routine immunization programmes, which are strengthening the fight to eradicate wild poliovirus (WPV).

This report studies the global Inactivated Polio Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Inactivated Polio Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inactivated Polio Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Inactivated Polio Vaccine total production and demand, 2018-2029, (K Dose)
Global Inactivated Polio Vaccine total production value, 2018-2029, (USD Million)
Global Inactivated Polio Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine consumption by region & country, CAGR, 2018-2029 & (K Dose)
U.S. VS China: Inactivated Polio Vaccine domestic production, consumption, key domestic manufacturers and share
Global Inactivated Polio Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
Global Inactivated Polio Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Dose)
This reports profiles key players in the global Inactivated Polio Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, Panacea Biotec, Bio-Med and Halfkin Bio-Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inactivated Polio Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Inactivated Polio Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Inactivated Polio Vaccine Market, Segmentation by Type
Government
Private Sector

Global Inactivated Polio Vaccine Market, Segmentation by Application
Pediatrics
Adults

Companies Profiled:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals

Key Questions Answered
1. How big is the global Inactivated Polio Vaccine market?
2. What is the demand of the global Inactivated Polio Vaccine market?
3. What is the year over year growth of the global Inactivated Polio Vaccine market?
4. What is the production and production value of the global Inactivated Polio Vaccine market?
5. Who are the key producers in the global Inactivated Polio Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Inactivated Polio Vaccine Introduction
    1.2 World Inactivated Polio Vaccine Supply & Forecast
        1.2.1 World Inactivated Polio Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Inactivated Polio Vaccine Production (2018-2029)
        1.2.3 World Inactivated Polio Vaccine Pricing Trends (2018-2029)
    1.3 World Inactivated Polio Vaccine Production by Region (Based on Production Site)
        1.3.1 World Inactivated Polio Vaccine Production Value by Region (2018-2029)
        1.3.2 World Inactivated Polio Vaccine Production by Region (2018-2029)
        1.3.3 World Inactivated Polio Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Inactivated Polio Vaccine Production (2018-2029)
        1.3.5 Europe Inactivated Polio Vaccine Production (2018-2029)
        1.3.6 China Inactivated Polio Vaccine Production (2018-2029)
        1.3.7 Japan Inactivated Polio Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Inactivated Polio Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Inactivated Polio Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Inactivated Polio Vaccine Demand (2018-2029)
    2.2 World Inactivated Polio Vaccine Consumption by Region
        2.2.1 World Inactivated Polio Vaccine Consumption by Region (2018-2023)
        2.2.2 World Inactivated Polio Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Inactivated Polio Vaccine Consumption (2018-2029)
    2.4 China Inactivated Polio Vaccine Consumption (2018-2029)
    2.5 Europe Inactivated Polio Vaccine Consumption (2018-2029)
    2.6 Japan Inactivated Polio Vaccine Consumption (2018-2029)
    2.7 South Korea Inactivated Polio Vaccine Consumption (2018-2029)
    2.8 ASEAN Inactivated Polio Vaccine Consumption (2018-2029)
    2.9 India Inactivated Polio Vaccine Consumption (2018-2029)

3 World Inactivated Polio Vaccine Manufacturers Competitive Analysis
    3.1 World Inactivated Polio Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Inactivated Polio Vaccine Production by Manufacturer (2018-2023)
    3.3 World Inactivated Polio Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Inactivated Polio Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Inactivated Polio Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Inactivated Polio Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Inactivated Polio Vaccine in 2022
    3.6 Inactivated Polio Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Inactivated Polio Vaccine Market: Region Footprint
        3.6.2 Inactivated Polio Vaccine Market: Company Product Type Footprint
        3.6.3 Inactivated Polio Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Inactivated Polio Vaccine Production Value Comparison
        4.1.1 United States VS China: Inactivated Polio Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Inactivated Polio Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Inactivated Polio Vaccine Production Comparison
        4.2.1 United States VS China: Inactivated Polio Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Inactivated Polio Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Inactivated Polio Vaccine Consumption Comparison
        4.3.1 United States VS China: Inactivated Polio Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Inactivated Polio Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Inactivated Polio Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Inactivated Polio Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Inactivated Polio Vaccine Production (2018-2023)
    4.5 China Based Inactivated Polio Vaccine Manufacturers and Market Share
        4.5.1 China Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Inactivated Polio Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Inactivated Polio Vaccine Production (2018-2023)
    4.6 Rest of World Based Inactivated Polio Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Inactivated Polio Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Inactivated Polio Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Government
        5.2.2 Private Sector
    5.3 Market Segment by Type
        5.3.1 World Inactivated Polio Vaccine Production by Type (2018-2029)
        5.3.2 World Inactivated Polio Vaccine Production Value by Type (2018-2029)
        5.3.3 World Inactivated Polio Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Inactivated Polio Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pediatrics
        6.2.2 Adults
    6.3 Market Segment by Application
        6.3.1 World Inactivated Polio Vaccine Production by Application (2018-2029)
        6.3.2 World Inactivated Polio Vaccine Production Value by Application (2018-2029)
        6.3.3 World Inactivated Polio Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Details
        7.1.2 Sanofi Major Business
        7.1.3 Sanofi Inactivated Polio Vaccine Product and Services
        7.1.4 Sanofi Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Recent Developments/Updates
        7.1.6 Sanofi Competitive Strengths & Weaknesses
    7.2 GSK
        7.2.1 GSK Details
        7.2.2 GSK Major Business
        7.2.3 GSK Inactivated Polio Vaccine Product and Services
        7.2.4 GSK Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 GSK Recent Developments/Updates
        7.2.6 GSK Competitive Strengths & Weaknesses
    7.3 Bibcol
        7.3.1 Bibcol Details
        7.3.2 Bibcol Major Business
        7.3.3 Bibcol Inactivated Polio Vaccine Product and Services
        7.3.4 Bibcol Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Bibcol Recent Developments/Updates
        7.3.6 Bibcol Competitive Strengths & Weaknesses
    7.4 Serum Institute
        7.4.1 Serum Institute Details
        7.4.2 Serum Institute Major Business
        7.4.3 Serum Institute Inactivated Polio Vaccine Product and Services
        7.4.4 Serum Institute Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Serum Institute Recent Developments/Updates
        7.4.6 Serum Institute Competitive Strengths & Weaknesses
    7.5 Tiantan Biological
        7.5.1 Tiantan Biological Details
        7.5.2 Tiantan Biological Major Business
        7.5.3 Tiantan Biological Inactivated Polio Vaccine Product and Services
        7.5.4 Tiantan Biological Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Tiantan Biological Recent Developments/Updates
        7.5.6 Tiantan Biological Competitive Strengths & Weaknesses
    7.6 Panacea Biotec
        7.6.1 Panacea Biotec Details
        7.6.2 Panacea Biotec Major Business
        7.6.3 Panacea Biotec Inactivated Polio Vaccine Product and Services
        7.6.4 Panacea Biotec Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Panacea Biotec Recent Developments/Updates
        7.6.6 Panacea Biotec Competitive Strengths & Weaknesses
    7.7 Bio-Med
        7.7.1 Bio-Med Details
        7.7.2 Bio-Med Major Business
        7.7.3 Bio-Med Inactivated Polio Vaccine Product and Services
        7.7.4 Bio-Med Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Bio-Med Recent Developments/Updates
        7.7.6 Bio-Med Competitive Strengths & Weaknesses
    7.8 Halfkin Bio-Pharmaceuticals
        7.8.1 Halfkin Bio-Pharmaceuticals Details
        7.8.2 Halfkin Bio-Pharmaceuticals Major Business
        7.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
        7.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
        7.8.6 Halfkin Bio-Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Inactivated Polio Vaccine Industry Chain
    8.2 Inactivated Polio Vaccine Upstream Analysis
        8.2.1 Inactivated Polio Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Inactivated Polio Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Inactivated Polio Vaccine Production Mode
    8.6 Inactivated Polio Vaccine Procurement Model
    8.7 Inactivated Polio Vaccine Industry Sales Model and Sales Channels
        8.7.1 Inactivated Polio Vaccine Sales Model
        8.7.2 Inactivated Polio Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Inactivated Polio Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Inactivated Polio Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Inactivated Polio Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Inactivated Polio Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Inactivated Polio Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Inactivated Polio Vaccine Production by Region (2018-2023) & (K Dose)
    Table 7. World Inactivated Polio Vaccine Production by Region (2024-2029) & (K Dose)
    Table 8. World Inactivated Polio Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Inactivated Polio Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Inactivated Polio Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 11. World Inactivated Polio Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 12. Inactivated Polio Vaccine Major Market Trends
    Table 13. World Inactivated Polio Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Dose)
    Table 14. World Inactivated Polio Vaccine Consumption by Region (2018-2023) & (K Dose)
    Table 15. World Inactivated Polio Vaccine Consumption Forecast by Region (2024-2029) & (K Dose)
    Table 16. World Inactivated Polio Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Inactivated Polio Vaccine Producers in 2022
    Table 18. World Inactivated Polio Vaccine Production by Manufacturer (2018-2023) & (K Dose)
    Table 19. Production Market Share of Key Inactivated Polio Vaccine Producers in 2022
    Table 20. World Inactivated Polio Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 21. Global Inactivated Polio Vaccine Company Evaluation Quadrant
    Table 22. World Inactivated Polio Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Inactivated Polio Vaccine Production Site of Key Manufacturer
    Table 24. Inactivated Polio Vaccine Market: Company Product Type Footprint
    Table 25. Inactivated Polio Vaccine Market: Company Product Application Footprint
    Table 26. Inactivated Polio Vaccine Competitive Factors
    Table 27. Inactivated Polio Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Inactivated Polio Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Inactivated Polio Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Inactivated Polio Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 31. United States VS China Inactivated Polio Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Dose)
    Table 32. United States Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Inactivated Polio Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Inactivated Polio Vaccine Production (2018-2023) & (K Dose)
    Table 36. United States Based Manufacturers Inactivated Polio Vaccine Production Market Share (2018-2023)
    Table 37. China Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Inactivated Polio Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Inactivated Polio Vaccine Production (2018-2023) & (K Dose)
    Table 41. China Based Manufacturers Inactivated Polio Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Inactivated Polio Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Inactivated Polio Vaccine Production (2018-2023) & (K Dose)
    Table 46. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Market Share (2018-2023)
    Table 47. World Inactivated Polio Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Inactivated Polio Vaccine Production by Type (2018-2023) & (K Dose)
    Table 49. World Inactivated Polio Vaccine Production by Type (2024-2029) & (K Dose)
    Table 50. World Inactivated Polio Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Inactivated Polio Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Inactivated Polio Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 53. World Inactivated Polio Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 54. World Inactivated Polio Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Inactivated Polio Vaccine Production by Application (2018-2023) & (K Dose)
    Table 56. World Inactivated Polio Vaccine Production by Application (2024-2029) & (K Dose)
    Table 57. World Inactivated Polio Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Inactivated Polio Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Inactivated Polio Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 60. World Inactivated Polio Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Major Business
    Table 63. Sanofi Inactivated Polio Vaccine Product and Services
    Table 64. Sanofi Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Recent Developments/Updates
    Table 66. Sanofi Competitive Strengths & Weaknesses
    Table 67. GSK Basic Information, Manufacturing Base and Competitors
    Table 68. GSK Major Business
    Table 69. GSK Inactivated Polio Vaccine Product and Services
    Table 70. GSK Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. GSK Recent Developments/Updates
    Table 72. GSK Competitive Strengths & Weaknesses
    Table 73. Bibcol Basic Information, Manufacturing Base and Competitors
    Table 74. Bibcol Major Business
    Table 75. Bibcol Inactivated Polio Vaccine Product and Services
    Table 76. Bibcol Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Bibcol Recent Developments/Updates
    Table 78. Bibcol Competitive Strengths & Weaknesses
    Table 79. Serum Institute Basic Information, Manufacturing Base and Competitors
    Table 80. Serum Institute Major Business
    Table 81. Serum Institute Inactivated Polio Vaccine Product and Services
    Table 82. Serum Institute Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Serum Institute Recent Developments/Updates
    Table 84. Serum Institute Competitive Strengths & Weaknesses
    Table 85. Tiantan Biological Basic Information, Manufacturing Base and Competitors
    Table 86. Tiantan Biological Major Business
    Table 87. Tiantan Biological Inactivated Polio Vaccine Product and Services
    Table 88. Tiantan Biological Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Tiantan Biological Recent Developments/Updates
    Table 90. Tiantan Biological Competitive Strengths & Weaknesses
    Table 91. Panacea Biotec Basic Information, Manufacturing Base and Competitors
    Table 92. Panacea Biotec Major Business
    Table 93. Panacea Biotec Inactivated Polio Vaccine Product and Services
    Table 94. Panacea Biotec Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Panacea Biotec Recent Developments/Updates
    Table 96. Panacea Biotec Competitive Strengths & Weaknesses
    Table 97. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 98. Bio-Med Major Business
    Table 99. Bio-Med Inactivated Polio Vaccine Product and Services
    Table 100. Bio-Med Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Bio-Med Recent Developments/Updates
    Table 102. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 103. Halfkin Bio-Pharmaceuticals Major Business
    Table 104. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product and Services
    Table 105. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 106. Global Key Players of Inactivated Polio Vaccine Upstream (Raw Materials)
    Table 107. Inactivated Polio Vaccine Typical Customers
    Table 108. Inactivated Polio Vaccine Typical Distributors
List of Figure
    Figure 1. Inactivated Polio Vaccine Picture
    Figure 2. World Inactivated Polio Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Inactivated Polio Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Inactivated Polio Vaccine Production (2018-2029) & (K Dose)
    Figure 5. World Inactivated Polio Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 6. World Inactivated Polio Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Inactivated Polio Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Inactivated Polio Vaccine Production (2018-2029) & (K Dose)
    Figure 9. Europe Inactivated Polio Vaccine Production (2018-2029) & (K Dose)
    Figure 10. China Inactivated Polio Vaccine Production (2018-2029) & (K Dose)
    Figure 11. Japan Inactivated Polio Vaccine Production (2018-2029) & (K Dose)
    Figure 12. Inactivated Polio Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 15. World Inactivated Polio Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 17. China Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 18. Europe Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 19. Japan Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 20. South Korea Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 21. ASEAN Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 22. India Inactivated Polio Vaccine Consumption (2018-2029) & (K Dose)
    Figure 23. Producer Shipments of Inactivated Polio Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Inactivated Polio Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Inactivated Polio Vaccine Markets in 2022
    Figure 26. United States VS China: Inactivated Polio Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Inactivated Polio Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Inactivated Polio Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Inactivated Polio Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Inactivated Polio Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Inactivated Polio Vaccine Production Market Share 2022
    Figure 32. World Inactivated Polio Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Inactivated Polio Vaccine Production Value Market Share by Type in 2022
    Figure 34. Government
    Figure 35. Private Sector
    Figure 36. World Inactivated Polio Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Inactivated Polio Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Inactivated Polio Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 39. World Inactivated Polio Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Inactivated Polio Vaccine Production Value Market Share by Application in 2022
    Figure 41. Pediatrics
    Figure 42. Adults
    Figure 43. World Inactivated Polio Vaccine Production Market Share by Application (2018-2029)
    Figure 44. World Inactivated Polio Vaccine Production Value Market Share by Application (2018-2029)
    Figure 45. World Inactivated Polio Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 46. Inactivated Polio Vaccine Industry Chain
    Figure 47. Inactivated Polio Vaccine Procurement Model
    Figure 48. Inactivated Polio Vaccine Sales Model
    Figure 49. Inactivated Polio Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
Panacea Biotec
Bio-Med
Halfkin Bio-Pharmaceuticals

Related Reports

Global Inactivated Polio Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Inactivated Polio Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 01 Apr 2021

date Pharma & Healthcare

The Inactivated Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Inactivated Polio Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Inactivated Polio Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Pharma & Healthcare

Global Inactivated Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Inactivated Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 10 Jan 2023

date Pharma & Healthcare

Global Inactivated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Inactivated Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Inactivated Polio Vaccine market size was valued at USD 708.4 million in 2023 and is forecast to a readjusted size of USD 945.6 million by 2030 with a CAGR of 4.2% during review period.

Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2024-2030

Global Inactivated Polio Vaccine Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Inactivated Polio Vaccine market size is expected to reach $ 945.6 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

Product Tags

inactivated polio vaccine

sabin inactivated polio vaccine sipv

Sabin Inactivated Polio vaccine (sIPV)

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>